SCHEMBL17422809

SCHEMBL17422809

Cn1c(I)cc2cc(Br)ccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.54
MAPT P10636 4/20 0.37
ALDH1A1 P00352 3/20 0.37
RAB9A P51151 2/20 0.37
MAPK1 P28482 2/20 0.37
ROCK1 Q13464 1/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
CYP2A6 P11509 1/20 0.35
SLC6A2 P23975 1/20 0.34
HTR7 P34969 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
HTT P42858 2/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17422832 0.84 MCL1 (0.39) MCL1MAPTALDH1A1RAB9AMAPK1
SCHEMBL21812440 0.79 MCL1 (0.58) MCL1MAPTALDH1A1RAB9AMAPK1
SCHEMBL2382747 0.78 MCL1 (0.56) MCL1MAPTALDH1A1RAB9AMAPK1
SCHEMBL8899119 0.76 RXFP1 (0.46) MAPTHTR2AHTR2CMEN1KMT2A
SCHEMBL19252189 0.76 MCL1 (0.39) MCL1MAPTTP53SMN1; SMN2HTR2A
SCHEMBL16440989 0.73 MCL1 (0.51) MCL1MAPTALDH1A1RAB9AMAPK1
SCHEMBL17422764 0.73 MCL1 (0.41) MCL1MAPTSMN1; SMN2HTR2AHTR2C
SCHEMBL4177987 0.72 KMT2A (0.53) MCL1MAPTALDH1A1SMN1; SMN2HTR2A
SCHEMBL31914845 0.72 KMT2A (0.53) MCL1MAPTALDH1A1SMN1; SMN2HTR2A
SCHEMBL17422772 0.72 MAPT (0.41) MCL1MAPTRAB9ATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170216252-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS SIMON FRASER UNIVERSITY (CA) 2017-08-03 US disclosed
WO-2016004513-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS SIMON FRASER UNIVERSITY (CA) 2016-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170216252-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS PDK1, PDK3, PDK2 MCL1 2005/4885MAPT 3760/4885ALDH1A1 2424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.